BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Houston Medical Robotics Receives FDA 510(k) Clearance for Euclid™ Tier 1 Mini Access System


3/6/2012 7:43:54 AM

HOUSTON, March 5, 2012 /PRNewswire/ -- Houston Medical Robotics, Inc. announces that it has received U.S. Food and Drug Administration 510(k) clearance to market the Euclid Tier 1 Mini Access System. The Euclid Tier 1 Mini Access System is a portable, hand-held device that integrates commercially available ultrasound imaging systems to facilitate placement of a needle and guidewire into a targeted anatomical location for a variety of therapeutics applications.

"Although numerous applications have been identified, our initial target for the Euclid Tier 1 Mini Access System is reducing complications associated with central venous catheter (CVC) placement," stated Jeffery J. Sheldon, Houston Medical Robotics, Inc. Chairman & CEO. "With over 5 million CVCs placed each year - and published complication rates are as high as 26% - we are poised to make a significant impact on healthcare outcomes," stated Mr. Sheldon.

Technology limitations, inadequate procedure training & exposure, and varying patient size & morphology have all been identified as co-contributors to the high CVC placement complication rates. Use of ultrasound imaging during procedures has been shown to reduce complications; however, the procedure is cumbersome and generally requires additional assistance. "The Euclid Tier 1 Mini Access System places all the necessary tools and consumables readily at hand for single-operator safe, effective, rapid, and cost-effective access," stated Mr. Sheldon.

About Houston Medical Robotics, Inc.

Houston Medical Robotics, Inc. develops & commercializes revolutionary image guided hand-held medical robotics for use in various therapeutic applications. The devices provide safer, cheaper, and more effective procedure alternatives, thereby increasing caregiver efficiency, hospital & clinic revenue, and overall patient satisfaction. Houston Medical Robotics, Inc. raised $2.2 million from CitareTx Investment Partners I, LP, a Texas based medical device investment fund and business incubator, also founded and managed by Mr. Sheldon.

Contact: Jeffery J. Sheldon - Founder, Chairman & CEO, Houston Medical Robotics, Inc., +1-281-984-7368 (office), +1-281-984-7374 (fax), or +1-832-455-3173 (mobile), jsheldon@hmrobotics.com

SOURCE Houston Medical Robotics, Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->